I earned my PhD in Biotechnology from the Polytechnic University of Valencia, where I investigated a novel Notch signaling mechanism mediated by exosomes and its implications in cardiovascular regeneration and breast cancer. Additionally, my research explored exosome biology in various contexts, including cardiac metabolism and neuroinflammation.
From 2020 to 2023, I conducted postdoctoral research at AstraZeneca in Göteborg, Sweden, focusing on the therapeutic potential of extracellular vesicles (EVs) in cardiovascular diseases, their tropism, and the role of regulatory T cells (Tregs) in graft-versus-host responses.
In 2023, I transitioned into the role of Senior Research Scientist in the Cell Therapy department at AstraZeneca, where I contributed to multiple projects while deepening my expertise in Treg and macrophage biology and their therapeutic applications.
Since 2024, I have been a Senior Research Scientist in the Respiratory & Immunology department, focusing on Treg-based therapies and EV-driven treatments for inflammatory and cardiovascular diseases. My work bridges academic research and pharmaceutical innovation, with the goal of developing next-generation immunotherapies.
I earned my PhD in Biotechnology from the Polytechnic University of Valencia, where I investigated a novel Notch signaling mechanism mediated by exosomes and its implications in cardiovascular regeneration and breast cancer. Additionally, my research explored exosome biology in various contexts, including cardiac metabolism and neuroinflammation.
From 2020 to 2023, I conducted postdoctoral research at AstraZeneca in Göteborg, Sweden, focusing on the therapeutic potential of extracellular vesicles (EVs) in cardiovascular diseases, their tropism, and the role of regulatory T cells (Tregs) in graft-versus-host responses.
In 2023, I transitioned into the role of Senior Research Scientist in the Cell Therapy department at AstraZeneca, where I contributed to multiple projects while deepening my expertise in Treg and macrophage biology and their therapeutic applications.
Since 2024, I have been a Senior Research Scientist in the Respiratory & Immunology department, focusing on Treg-based therapies and EV-driven treatments for inflammatory and cardiovascular diseases. My work bridges academic research and pharmaceutical innovation, with the goal of developing next-generation immunotherapies.